comparemela.com

Latest Breaking News On - Bicycle therapeutics company profile - Page 5 : comparemela.com

Bicycle Therapeutics (NASDAQ:BCYC) Sees Large Volume Increase

Bicycle Therapeutics (NASDAQ:BCYC) Sees Large Volume Increase
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Kevin-lee
Securities-exchange-commission
Tower-research-capital
Exchange-traded-concepts
Ef-hutton-acquisition-co
Bicycle-therapeutics-company-profile
Nasdaq
Bicycle-therapeutics
Get-free-report
Therapeutics-trading-down
Exchange-commission

Michael Skynner Sells 451 Shares of Bicycle Therapeutics plc (NASDAQ:BCYC) Stock

Bicycle Therapeutics plc (NASDAQ:BCYC – Free Report) CTO Michael Skynner sold 451 shares of the firm’s stock in a transaction that occurred on Monday, July 3rd. The stock was sold at an average price of $25.10, for a total transaction of $11,320.10. Following the sale, the chief technology officer now owns 70,924 shares of the […]

Michael-skynner
Armistice-capital
Bicycle-therapeutics-company-profile
Sio-capital-management
Nasdaq
First-light-asset-management
Loomis-sayles-co
Ef-hutton-acquisition-co
Bicycle-therapeutics
Free-report
Capital-management

Bicycle Therapeutics plc (NASDAQ:BCYC) CTO Sells $11,320.10 in Stock

Bicycle Therapeutics plc (NASDAQ:BCYC – Free Report) CTO Michael Skynner sold 451 shares of the business’s stock in a transaction on Monday, July 3rd. The stock was sold at an average price of $25.10, for a total transaction of $11,320.10. Following the completion of the sale, the chief technology officer now owns 70,924 shares in […]

Michael-skynner
Loomis-sayles-co
Vident-investment-advisory
Jpmorgan-chase-co
Bicycle-therapeutics-company-profile
Securities-exchange-commission
Nasdaq
Ef-hutton-acquisition-co
Bicycle-therapeutics
Free-report
Exchange-commission

Bicycle Therapeutics plc (NASDAQ:BCYC) Given Consensus Rating of "Moderate Buy" by Analysts

Shares of Bicycle Therapeutics plc (NASDAQ:BCYC – Get Rating) have received an average rating of “Moderate Buy” from the twelve research firms that are currently covering the firm, MarketBeat Ratings reports. One equities research analyst has rated the stock with a hold rating and ten have issued a buy rating on the company. The average […]

Kevin-lee
Cantor-fitzgerald
Nasdaq
Ef-hutton-acquisition-co
Securities-exchange-commission
Bicycle-therapeutics-company-profile
Needham-company
Tower-research-capital
Bicycle-therapeutics-plc
Bicycle-therapeutics
Get-rating
Marketbeat-ratings

Analysts Set Bicycle Therapeutics plc (NASDAQ:BCYC) Price Target at $53.20

Shares of Bicycle Therapeutics plc (NASDAQ:BCYC – Get Rating) have earned a consensus recommendation of “Moderate Buy” from the twelve ratings firms that are presently covering the firm, Marketbeat.com reports. One investment analyst has rated the stock with a hold rating and ten have assigned a buy rating to the company. The average 1-year price […]

Kevin-lee
Nasdaq
Tower-research-capital
Securities-exchange-commission
Needham-company
Points-wealth-management
Ef-hutton-acquisition-co
Bicycle-therapeutics-plc
Bicycle-therapeutics-company-profile
Cantor-fitzgerald
Bicycle-therapeutics
Get-rating

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.